MarketAnalysis市场分析
NASDAQ:FBRX

Forte Biosciences, Inc. - NASDAQ:FBRX - Comprehensive analysis

Free evaluation through quantitative algorithms Forte Biosciences, Inc. - NASDAQ:FBRX

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

0

Market

30

Sector

40

Gross Profit Growth Over Prior Year

0

Market

25

Sector

40

EBITDA Growth Over Prior Year

0

Market

32

Sector

45

EBITA Growth Over Prior Year

0

Market

0

Sector

0

EBIT Growth Over Prior Year

0

Market

0

Sector

0

Earnings from Cont. Ops. Growth Over Prior Year

0

Market

0

Sector

0

Net Income Growth Over Prior Year

0

Market

0

Sector

0

Normalized Net Income Growth Over Prior Year

0

Market

0

Sector

0

Diluted EPS before Extra Growth Over Prior Year

0

Market

0

Sector

0

A/R Growth Over Prior Year

0

Market

35

Sector

43

Inventory Growth Over Prior Year

0

Market

62

Sector

48

PPE Net Growth Over Prior Year

-12.24

Market

3

Sector

36

Total Assets Growth Over Prior Year

-62.52

Market

1

Sector

5

Tangible Book Value Growth Over Prior Year

-76.82

Market

1

Sector

5

Common Equity Growth Over Prior Year

-76.82

Market

0

Sector

5

Cash from Ops. Growth Over Prior Year

0

Market

0

Sector

0

CAPEX Growth Over Prior Year

-67.61

Market

1

Sector

22

Dividend per Share Growth Over Prior Year

0

Market

35

Sector

49

Levered Free Cash Flow Growth Over Prior Year

0

Market

0

Sector

0

Unlevered Free Cash Flow Growth Over Prior Year

0

Market

0

Sector

0

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

0

Market

5

Sector

27

SG&A Margin %

0

Market

7

Sector

15

EBITDA Margin %

0

Market

2

Sector

52

EBITA Margin %

0

Market

7

Sector

54

EBIT Margin %

0

Market

3

Sector

56

Earnings from Cont. Ops Margin %

0

Market

6

Sector

61

Net Income Margin %

0

Market

6

Sector

62

Net Income Avail. for Common Margin %

0

Market

6

Sector

62

Normalized Net Income Margin %

0

Market

2

Sector

59

Levered Free Cash Flow Margin %

0

Market

21

Sector

51

Unlevered Free Cash Flow Margin %

0

Market

19

Sector

49

Return on Assets %

-67.66

Market

0

Sector

13

Return on Capital %

-89.48

Market

0

Sector

13

Return on Equity %

-137.4

Market

0

Sector

21

Return on Common Equity %

-137.4

Market

0

Sector

22

Total Asset Turnover

0

Market

5

Sector

15

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 80
Momentum: 71
Growth: 20
Profitability: 6

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

0

Market

0

Sector

0

TEV/LTM EBITDA

0

Market

0

Sector

0

P/LTM Normalized EPS

0

Market

0

Sector

0

P/BV

1.9

Market

23

Sector

46

TEV/LTM Unlevered FCF

0

Market

0

Sector

0

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

11.01

Market

90

Sector

68

3M Price Performance

30.3

Market

94

Sector

73

6M Price Performance

21.7

Market

86

Sector

73

9M Price Performance

-31.1

Market

6

Sector

38

1Y Price Performance

28.5

Market

78

Sector

79

Start analyzing Forte Biosciences, Inc. - NASDAQ:FBRX with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports